{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:55:04Z","timestamp":1783425304009,"version":"3.54.6"},"reference-count":38,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.3892\/ijo.2015.3277","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T17:18:32Z","timestamp":1449595112000},"page":"836-842","source":"Crossref","is-referenced-by-count":15,"title":["Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells"],"prefix":"10.3892","volume":"48","author":[{"given":"DONG YOUNG","family":"KANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PRAMOD","family":"DARVIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOUNG BEOM","family":"YOO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOUN HEE","family":"JOUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NIPIN","family":"SP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HYO JOO","family":"BYUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOUNG MOK","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,12,7]]},"reference":[{"key":"key20180107185438_b1-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107185438_b2-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5122(00)00196-1","article-title":"Breast cancer: Hormones and other risk factors","volume":"38","author":"Hulka","year":"2001","journal-title":"Maturitas"},{"key":"key20180107185438_b3-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1470-2045(07)70099-2","article-title":"WHO International Agency for Research on Cancer Monograph Working Group: Carcinogenicity of alcoholic beverages","volume":"8","author":"Baan","year":"2007","journal-title":"Lancet Oncol"},{"key":"key20180107185438_b4-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10552-006-0011-0","article-title":"Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues","volume":"17","author":"Key","year":"2006","journal-title":"Cancer Causes Control"},{"key":"key20180107185438_b5-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/156652412798376134","article-title":"Basal breast cancer: A complex and deadly molecular subtype","volume":"12","author":"Bertucci","year":"2012","journal-title":"Curr Mol Med"},{"key":"key20180107185438_b6-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2174\/092986713804999303","article-title":"Treatment of estrogen receptor-positive breast cancer","volume":"20","author":"Lumachi","year":"2013","journal-title":"Curr Med Chem"},{"key":"key20180107185438_b7-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1200\/JCO.2011.36.1105","article-title":"Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy","volume":"29","author":"Arvold","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20180107185438_b8-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"Carey","year":"2006","journal-title":"JAMA"},{"key":"key20180107185438_b9-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000090986","article-title":"Prognostic relevance of basal cytokeratin expression in operable breast cancer","volume":"69","author":"Potemski","year":"2005","journal-title":"Oncology"},{"key":"key20180107185438_b10-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: Clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107185438_b11-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/cncr.25016","article-title":"Age\/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: A population-based study and first report","volume":"116","author":"Lund","year":"2010","journal-title":"Cancer"},{"issue":"Suppl 2","key":"key20180107185438_b12-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.3816\/CBC.2009.s.005","article-title":"Treatment of HER2-positive metastatic breast cancer following initial progression","volume":"9","author":"Mayer","year":"2009","journal-title":"Clin Breast Cancer"},{"key":"key20180107185438_b13-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107185438_b14-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: Correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"key20180107185438_b15-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"key20180107185438_b16-ijo-48-02-0836","first-page":"410","article-title":"HER2-positive breast cancer: Beyond trastuzumab","volume":"24","author":"Murphy","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"key20180107185438_b17-ijo-48-02-0836","doi-asserted-by":"crossref","DOI":"10.5772\/53921","volume-title":"HER2 Amplification or Overexpression in Upper GI Tract and Breast Cancer with Clinical Diagnosis and Treatment","author":"Zhou","year":"2013"},{"key":"key20180107185438_b18-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/72294","article-title":"The Ets protein PEA3 suppresses HER-2\/neu overexpression and inhibits tumorigenesis","volume":"6","author":"Xing","year":"2000","journal-title":"Nat Med"},{"key":"key20180107185438_b19-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.mce.2013.03.023","article-title":"STAT signaling in different breast cancer sub-types","volume":"382","author":"Furth","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"key20180107185438_b20-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.onc.1203527","article-title":"STATs in oncogenesis","volume":"19","author":"Bowman","year":"2000","journal-title":"Oncogene"},{"key":"key20180107185438_b21-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1158\/1078-0432.CCR-12-1436","article-title":"HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells","volume":"18","author":"Duru","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107185438_b22-ijo-48-02-0836","article-title":"MSM reviewed","volume":"7","author":"William","year":"1987","journal-title":"J Equine Vet Sci"},{"key":"key20180107185438_b23-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/jf025934g","article-title":"Influence of some technological parameters on the formation of dimethyl sulfide, 2-mercaptoethanol, methionol, and dimethyl sulfone in port wines","volume":"51","author":"Silva Ferreira","year":"2003","journal-title":"J Agric Food Chem"},{"key":"key20180107185438_b24-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0730-725X(99)00110-1","article-title":"Detection of dimethyl sulfone in the human brain by in vivo proton magnetic resonance spectroscopy","volume":"18","author":"Rose","year":"2000","journal-title":"Magn Reson Imaging"},{"key":"key20180107185438_b25-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"e11788","DOI":"10.1371\/journal.pone.0011788","article-title":"Methyl sulfone induces loss of metastatic properties and reemergence of normal phenotypes in a metastatic cloudman S-91 (M3) murine melanoma cell line","volume":"5","author":"Caron","year":"2010","journal-title":"PLoS One"},{"key":"key20180107185438_b26-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/107555302317371451","article-title":"A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis","volume":"8","author":"Barrager","year":"2002","journal-title":"J Altern Complement Med"},{"key":"key20180107185438_b27-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.joca.2005.10.003","article-title":"Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: A pilot clinical trial","volume":"14","author":"Kim","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"key":"key20180107185438_b28-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"e47477","DOI":"10.1371\/journal.pone.0047477","article-title":"MSM enhances GH signaling via the Jak2\/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs","volume":"7","author":"Joung","year":"2012","journal-title":"PLoS One"},{"key":"key20180107185438_b29-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"e33361","DOI":"10.1371\/journal.pone.0033361","article-title":"Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways","volume":"7","author":"Lim","year":"2012","journal-title":"PLoS One"},{"key":"key20180107185438_b30-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4254\/wjh.v6.i2.98","article-title":"Methylsulfonylmethane suppresses hepatic tumor development through activation of apoptosis","volume":"6","author":"Kim","year":"2014","journal-title":"World J Hepatol"},{"key":"key20180107185438_b31-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2217\/bmm.11.31","article-title":"Update on HER2 testing for breast and upper gastrointestinal tract cancers","volume":"5","author":"Ross","year":"2011","journal-title":"Biomarkers Med"},{"key":"key20180107185438_b32-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/bjc.1991.103","article-title":"The long term prognostic significance of c-erbB-2 in primary breast cancer","volume":"63","author":"Winstanley","year":"1991","journal-title":"Br J Cancer"},{"key":"key20180107185438_b33-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1158\/1078-0432.CCR-06-0635","article-title":"Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients","volume":"12","author":"Hicks","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107185438_b34-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1586\/era.10.226","article-title":"HER2-amplified breast cancer: Mechanisms of trastuzumab resistance and novel targeted therapies","volume":"11","author":"Gajria","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"issue":"Suppl 1","key":"key20180107185438_b35-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.critrevonc.2010.09.002","article-title":"Association of Radiotherapy and Oncology of the Mediterranean arEa (AROME): Therapeutic strategies and mechanisms of tumorigenesis of HER2-over-expressing breast cancer","volume":"84","author":"Emde","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180107185438_b36-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3892\/ijo.2013.2195","article-title":"STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits","volume":"44","author":"Chung","year":"2014","journal-title":"Int J Oncol"},{"key":"key20180107185438_b37-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/117822341000400004","article-title":"The expression patterns of ER, PR, HER2, CK5\/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines","volume":"4","author":"Subik","year":"2010","journal-title":"Breast Cancer (Auckl)"},{"key":"key20180107185438_b38-ijo-48-02-0836","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/emm.2005.45","article-title":"Hypoxia activates the cyclin D1 promoter via the Jak2\/STAT5b pathway in breast cancer cells","volume":"37","author":"Joung","year":"2005","journal-title":"Exp Mol Med"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2015.3277\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T17:50:48Z","timestamp":1748713848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2015.3277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,7]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,12,7]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.3892\/ijo.2015.3277"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2015.3277","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,7]]}}}